Shares of Recursion Pharmaceuticals (RXRX) spiked on Wednesday after the AI-driven drug developer significantly exceeded Street forecasts with its Q4 2025 financials, thanks primarily to a milestone ...
This is read by an automated voice. Please report any issues or inconsistencies here. Floyd Mayweather Jr. and Manny Pacquiao will have a rematch Sept. 19 at Las Vegas’ Sphere, more than a decade ...
Floyd Mayweather Jr. is back. The legendary boxer announced Friday that he is coming out of retirement and returning to boxing after his exhibition bout with Mike Tyson on April 25 in the Democratic ...
Feb 21 (Reuters) - Former multi-weight world boxing champion Floyd Mayweather will come out of retirement this year for his first official fight in nearly a decade, his new promotion CSI Sports/Fight ...
Floyd Mayweather is coming out of retirement. Mayweather announced that he will compete professionally in boxing after an exhibition fight with Mike Tyson in the spring. Mayweather will end his ...
Floyd Mayweather Jr. has announced a return to boxing after retiring from the sport nearly 10 years ago. Mayweather, 48, said that through a partnership with CSI Sports/FIGHT SPORTS, he would return ...
This is read by an automated voice. Please report any issues or inconsistencies here. Floyd Mayweather Jr., one of history’s most successful professional boxers, is suing Showtime and a former ...
Almost eight years after retiring from professional boxing, Floyd Mayweather Jr. is climbing into the legal ring to take on Paramount-owned Showtime over “hundreds of millions of dollars in the ...
Legendary New Jersey comedian Floyd Vivino, known as “Uncle Floyd,” has died at 74. On Friday, his brother, musician Jerry Vivino, announced on social media that Floyd had passed away the previous day ...
Floyd Vivino, best known as the beloved comedian, musician and TV personality "Uncle Floyd" who became a fixture in New Jersey culture, has died. He was 74. Jerry Vivino, Uncle Floyd's brother, shared ...
Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results